{"id":724,"date":"2026-09-01T15:21:54","date_gmt":"2026-09-01T15:21:54","guid":{"rendered":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/"},"modified":"2026-09-01T15:32:23","modified_gmt":"2026-09-01T15:32:23","slug":"cjc-1295-dac-randomized-human-pharmacology","status":"publish","type":"case_study","link":"https:\/\/nhdbio.com\/es\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","title":{"rendered":"CJC-1295 con DAC: farmacolog\u00eda humana aleatoria y el l\u00edmite de uni\u00f3n a alb\u00famina"},"content":{"rendered":"<h2>La cuesti\u00f3n de la identidad antecede al resultado<\/h2>\n<p>El compuesto citado fue dise\u00f1ado como un an\u00e1logo de GHRH de acci\u00f3n prolongada que se une a la alb\u00famina end\u00f3gena. Esa caracter\u00edstica de dise\u00f1o es fundamental para la cuesti\u00f3n farmacocin\u00e9tica. Las p\u00e1ginas de b\u00fasqueda frecuentemente agrupan \u201ccon DAC\u201d y \u201csin DAC\u201d en un solo nombre, pero al hacerlo se cambia la identidad molecular e invalida una transferencia directa de la vida media informada.<\/p>\n<h2>Lo que midieron los ensayos<\/h2>\n<p>Los dos ensayos fueron aleatorios, controlados con placebo, doble ciego y de dosis ascendente. Sus principales resultados fueron la exposici\u00f3n circulante a GH y IGF-I m\u00e1s los par\u00e1metros farmacocin\u00e9ticos. Esos son criterios de valoraci\u00f3n farmacol\u00f3gicos. No son medidas directas de mejora de la salud, la composici\u00f3n corporal o el rendimiento.<\/p>\n<h2>El curso del tiempo reportado<\/h2>\n<p>Los autores informaron aumentos sostenidos y dependientes de la dosis de GH y IGF-I y una vida media estimada medida en d\u00edas. Un estudio complementario inform\u00f3 que la secreci\u00f3n puls\u00e1til de GH permaneci\u00f3 observable bajo el est\u00edmulo prolongado. Estos registros respaldan una discusi\u00f3n mecanicista y de curso temporal para el formulario DAC \u00fanicamente.<\/p>\n<div class=\"pfm-case-callout\"><strong>Verificaci\u00f3n de nombre:<\/strong> una p\u00e1gina que utiliza la prueba cl\u00e1sica CJC-1295 para describir \u201cCJC-1295 sin DAC\u201d est\u00e1 mezclando dos materiales distintos. La identidad del producto debe coincidir con la intervenci\u00f3n citada antes de que se reutilice cualquier n\u00famero.<\/div>\n<h2>Lo que el estudio no establece<\/h2>\n<p>Los datos breves sobre exposici\u00f3n y hormonas de fase temprana no establecen la eficacia terap\u00e9utica, la seguridad a largo plazo ni la calidad de un lote comercial. Un lote actual requiere su propia documentaci\u00f3n de identidad, ensayo y autorizaci\u00f3n; La literatura no puede sustituir esos controles.<\/p>","protected":false},"excerpt":{"rendered":"<p>Una lectura detallada de los dos estudios aleatorios de dosis ascendentes en adultos sanos, centr\u00e1ndose en la evoluci\u00f3n temporal de GH y IGF-I, la vida media estimada y por qu\u00e9 los hallazgos no se aplican a CJC-1295 sin DAC.<\/p>","protected":false},"author":0,"featured_media":852,"template":"","class_list":["post-724","case_study","type-case_study","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CJC-1295 DAC Human Trial: GH, IGF-I and Half-Life<\/title>\n<meta name=\"description\" content=\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary\" \/>\n<meta property=\"og:description\" content=\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T15:32:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\",\"name\":\"CJC-1295 DAC Human Trial: GH, IGF-I and Half-Life\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"datePublished\":\"2026-09-01T15:21:54+00:00\",\"dateModified\":\"2026-09-01T15:32:23+00:00\",\"description\":\"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cjc-1295-dac-editorial-v2.webp\",\"width\":1672,\"height\":941,\"caption\":\"Editorial laboratory illustration; not an image of a supplied lot or a reported analytical result.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/cjc-1295-dac-randomized-human-pharmacology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u6848\u4f8b\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ensayo en humanos CJC-1295 DAC: GH, IGF-I y vida media","description":"Una lectura detallada de los dos estudios aleatorios de dosis ascendentes en adultos sanos, centr\u00e1ndose en la evoluci\u00f3n temporal de GH y IGF-I, la vida media estimada y por qu\u00e9 los hallazgos no se aplican a CJC-1295 sin DAC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","og_locale":"es_ES","og_type":"article","og_title":"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary","og_description":"A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.","og_url":"https:\/\/nhdbio.com\/es\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","og_site_name":"NHD","article_modified_time":"2026-09-01T15:32:23+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","url":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/","name":"Ensayo en humanos CJC-1295 DAC: GH, IGF-I y vida media","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","datePublished":"2026-09-01T15:21:54+00:00","dateModified":"2026-09-01T15:32:23+00:00","description":"Una lectura detallada de los dos estudios aleatorios de dosis ascendentes en adultos sanos, centr\u00e1ndose en la evoluci\u00f3n temporal de GH y IGF-I, la vida media estimada y por qu\u00e9 los hallazgos no se aplican a CJC-1295 sin DAC.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cjc-1295-dac-editorial-v2.webp","width":1672,"height":941,"caption":"Editorial laboratory illustration; not an image of a supplied lot or a reported analytical result."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/case-studies\/cjc-1295-dac-randomized-human-pharmacology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"\u6848\u4f8b","item":"https:\/\/nhdbio.com\/case-studies\/"},{"@type":"ListItem","position":3,"name":"CJC-1295 With DAC: Randomized Human Pharmacology and the Albumin-Binding Boundary"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/case_study\/724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/case_study"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/case_study\/724\/revisions"}],"predecessor-version":[{"id":729,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/case_study\/724\/revisions\/729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/852"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}